The Recall Desk
ModerateFDA (Devices)·Z-2200-2021·Announced 2021-08-11

Beta-Hydroxybutyrate Diagnostic Reagent Recalled for Stability Degradation

Stanbio Laboratory recalled Beta-Hydroxybutyrate Reagent A due to deterioration in reagent stability. The degradation resulted in out-of-range Quality Control values that could affect diagnostic accuracy.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA classified this as Class III. No illnesses, injuries, or reported test failures are documented in the source text. The hazard is potential unreliability of diagnostic results due to reagent degradation, which is theoretical with no actual harm reported.

Plain-English summary

Stanbio Laboratory, LP is recalling Beta-Hydroxybutyrate Reagent A - Enzyme (unlabeled), an in vitro diagnostic reagent used in laboratory testing. The product is identified by Lot Number 158894 and Catalog Number 2441-050U, with approximately 200 units distributed.

The recall was issued due to deterioration in the stability of the reagent. This degradation has resulted in lower than expected or out-of-range Quality Control values, which could compromise the reliability of diagnostic test results.

The affected product has been distributed worldwide, including throughout the United States and internationally to Australia, Canada, Chile, Germany, Hong Kong, Singapore, Taiwan, Thailand, United Kingdom, and Vietnam.

The recalled product

Product
Beta-Hydroxybutyrate Reagent A - Enzyme (unlabeled). in vitro diagnostic reagent.
Manufacturer
Stanbio Laboratory, LP
Hazard
  • reagent-degradation
  • invalid-test-results

Distribution

Distributed nationwide across the United States.